Brief: Michael Mahler, Phd Joins Exagen As Chief Scientific Officer To Enhance Leadership In Autoimmune Diagnostics
23/06/2025 14:02
June 23 (Reuters) - Exagen Inc XGN.O: MICHAEL MAHLER, PHD JOINS EXAGEN AS CHIEF SCIENTIFIC OFFICER TO ENHANCE LEADERSHIP IN AUTOIMMUNE DIAGNOSTICS Source text: ID:nGNX3NljTg Further company coverage: XGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance